{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:59:39Z","timestamp":1790657979799,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["22NSFSC0850"],"award-info":[{"award-number":["22NSFSC0850"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23830","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:35:59Z","timestamp":1702726559000},"page":"e23830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"Xingmei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangchuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoguo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaichao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.heliyon.2023.e23830_bib1","first-page":"409","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA A Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23830_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jtho.2017.10.010","article-title":"Combined small cell carcinoma of the lung: is it a single entity?","volume":"13","author":"Zhao","year":"2018","journal-title":"J. Thorac. Oncol.: Official Publication of the International Association For the Study of Lung Cancer"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23830_bib3","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3390\/cancers11091297","article-title":"Tumor-targeted drug conjugates as an emerging novel therapeutic approach in small cell lung cancer (SCLC)","volume":"11","author":"Deneka","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2023.e23830_bib4","first-page":"4094","article-title":"The addition of peripheral blood inflammatory indexes to nomogram improves the predictive accuracy of survival in limited-stage small cell lung cancer patients","author":"Qi","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23830_bib5","doi-asserted-by":"crossref","DOI":"10.21037\/atm-21-68","article-title":"A narrative review of current and potential prognostic biomarkers for immunotherapy in small-cell lung cancer","volume":"9","author":"Lim","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23830_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/cncr.29098","article-title":"Small cell lung cancer: where do we go from here?","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23830_bib7","first-page":"812","article-title":"Efficacy of surgery combined with chemoradiotherapy in treating limited-stage small cell lung cancer and prognosis analysis","volume":"26","author":"Gu","year":"2021","journal-title":"J BUON"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23830_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jtho.2019.11.030","article-title":"Validation of the eighth edition TNM lung cancer staging system","volume":"15","author":"Hwang","year":"2020","journal-title":"J. Thorac. Oncol.: Official Publication of the International Association For the Study of Lung Cancer"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23830_bib9","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/annonc\/mdz122","article-title":"Prognostic value of circulating tumor cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomized controlled trial","volume":"30","author":"Tay","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.heliyon.2023.e23830_bib10","doi-asserted-by":"crossref","DOI":"10.2147\/CMAR.S260599","article-title":"Pd-L1 predicts poor prognosis in surgically resected limited-stage small-cell lung cancer","volume":"12","author":"Fu","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.heliyon.2023.e23830_bib11","series-title":"Plasma Cell-free DNA as a Prognostic Biomarker in Small Cell Lung Cancer Patients","author":"Mondelo-Mac\u00eda","year":"2022"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23830_bib12","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1111\/jcmm.14116","article-title":"Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.heliyon.2023.e23830_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2018.06.033","article-title":"Circulating endothelial cells and microparticles as diagnostic and prognostic biomarkers in small-cell lung cancer","volume":"124","author":"Najjar","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.heliyon.2023.e23830_bib14","first-page":"220","article-title":"Prognostic significance of the systemic immune-inflammation index (SII) in patients with small cell lung cancer: a meta-analysis","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2023.e23830_bib15","series-title":"Mayo Clinic Proceedings","article-title":"Current diagnosis and management of small-cell lung cancer","author":"Wang","year":"2019"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e23830_bib16","article-title":"Clinical utility of immature reticulocyte fraction","volume":"4","author":"Adane","year":"2021","journal-title":"J Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23830_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.bmt.1705251","article-title":"Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients","volume":"37","author":"Grazziutti","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23830_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3329\/bmrcb.v37i2.8435","article-title":"Immature reticulocyte fraction as a predictor of bone marrow recovery in children with acute lymphoblastic leukemia on remission induction phase","volume":"37","author":"Yesmin","year":"2011","journal-title":"Bangladesh Med. Res. Counc. Bull."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23830_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cll.2014.10.004","article-title":"Clinical utility of reticulocyte parameters","volume":"35","author":"Piva","year":"2015","journal-title":"Clin. Lab. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23830_bib20","first-page":"259","article-title":"Assessment of immature platelet fraction and immature reticulocyte fraction as predictors of engraftment after hematopoietic stem cell transplantation","volume":"37","author":"Morkis","year":"2015","journal-title":"Int. J. Lit. Humanit."},{"key":"10.1016\/j.heliyon.2023.e23830_bib21","series-title":"Reticulocytes-Mother of Erythrocytes","author":"Gupta","year":"2022"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23830_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.15537\/1658-3175.5928","article-title":"Immature reticulocyte fraction is an early predictor of bone marrow recovery post-chemotherapy in patients with acute leukemia","volume":"35","author":"Raja-Sabudin","year":"2014","journal-title":"Saudi Med. J."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23830_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/09674845.2009.11730252","article-title":"Immature reticulocyte fraction as a useful parameter for blood transfusion assessment in anemia","volume":"66","author":"Geldard","year":"2009","journal-title":"Br. J. Biomed. Sci."},{"key":"10.1016\/j.heliyon.2023.e23830_bib24","first-page":"619","article-title":"Role of immature reticulocyte fraction in evaluation of aplastic anemia in cases of pancytopenia","volume":"5","author":"Sindhu","year":"2016","journal-title":"Int J Basic Appl Med Sci"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23830_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.6004\/jnccn.2020.7638","article-title":"Prevalence of anemia and compliance with NCCN guidelines for evaluation and treatment of anemia in patients with gynecologic cancer","volume":"19","author":"Hufnagel","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.heliyon.2023.e23830_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.844042","article-title":"Targeting stress erythropoiesis pathways in cancer","volume":"13","author":"Vignjevi\u0107 Petrinovi\u0107","year":"2022","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23830_bib27","article-title":"Reticulocyte count: a simple test but tricky interpretation!","volume":"40","author":"Gaur","year":"2021","journal-title":"Pan African Medical Journal"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e23830_bib28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.6004\/jnccn.2021.0058","article-title":"Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"19","author":"Ganti","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23830_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The eighth edition lung cancer stage classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23830_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"54","key":"10.1016\/j.heliyon.2023.e23830_bib31","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21439","article-title":"Red blood cell distribution width as a predictor of survival in nasal-type, extranodal natural killer\/T-cell lymphoma","volume":"8","author":"Luo","year":"2017","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.heliyon.2023.e23830_bib32","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23830_bib33","doi-asserted-by":"crossref","first-page":"bbac261","DOI":"10.1093\/bib\/bbac261","article-title":"Hiplot: a comprehensive and easy-to-use web service for boosting publication-ready biomedical data visualization","volume":"23","author":"Li","year":"2022","journal-title":"Briefings Bioinf."},{"issue":"29","key":"10.1016\/j.heliyon.2023.e23830_bib34","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.2217\/fon-2019-0288","article-title":"The predictive effect of the systemic immune-inflammation index for patients with small-cell lung cancer","volume":"15","author":"Wang","year":"2019","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23830_bib35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41598-023-27579-3","article-title":"Reference range of complete blood count, Ret-He, immature reticulocyte fraction, reticulocyte production index in healthy babies aged 1\u20134 months","volume":"13","author":"Ringoringo","year":"2023","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23830_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4274\/tjh.2014.0379","article-title":"Immature reticulocyte fraction and absolute neutrophil count as predictor of hemopoietic recovery in patients with acute lymphoblastic leukemia on remission induction chemotherapy","volume":"33","author":"Rauf","year":"2016","journal-title":"Turk. J. Haematol. : Official Journal of Turkish Society of Haematology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23830_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.21294\/1814-4861-2017-16-1-53-58","article-title":"Erythropoiesis reaction to tumor growth in lung cancer patients","volume":"16","author":"Ragulin","year":"2017","journal-title":"Siberian journal of oncology"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23830_bib38","first-page":"949","article-title":"Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer","volume":"2","author":"Kishida","year":"2011","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23830_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1179\/1607845414Y.0000000161","article-title":"Anemia in malignancies: pathogenetic and diagnostic considerations","volume":"20","author":"Gaspar","year":"2015","journal-title":"Hematology"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23830_bib40","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.7150\/thno.56202","article-title":"Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients","volume":"11","author":"Shi","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23830_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-022-04926-1","article-title":"Clinlabomics: leveraging clinical laboratory data by data mining strategies","volume":"23","author":"Wen","year":"2022","journal-title":"BMC Bioinf."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023110383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023110383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:46:30Z","timestamp":1790657190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023110383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023110383"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23830","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23830"}}